MedPath

Trial to Examine Text-message Based mHealth in Emergency Department Patients With Diabetes

Not Applicable
Completed
Conditions
Diabetes
Registration Number
NCT01403831
Lead Sponsor
University of Southern California
Brief Summary

The investigators propose an innovative, ED-based mHealth intervention: TExT-MED (Trial to Examine Text-Based mHealth for Emergency department patients with Diabetes). TExT-MED is a technologically simple solution using unidirectional daily text messages to consisting of educational materials, trivia questions and challenges promoting healthy lifestyle choices and reminders to check blood sugar, take medications and go to clinic appointments. The investigators believe TExT-MED will improve health outcomes including blood glucose control and encourage weight loss, healthy eating and exercise. TExT-MED is low cost, easy to use and can be quickly adapted to other practice environments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. ≥18 years old 2) have Type 2 diabetes 3) have a text message capable mobile phone 4) know how to receive text messages 5) speak and read English or Spanish and 6) have a HbA1C ≥8%.
Exclusion Criteria
  1. overt psychosis 2) unable to provide informed consent and 3) pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1C at 6 months6 months
Secondary Outcome Measures
NameTimeMethod
DIet/ Weight Loss6 months
Diabetes self-efficacy/empowerment6 months
Diabetes knowledge6 months

Trial Locations

Locations (1)

University of Southern California

🇺🇸

Los Angeles, California, United States

University of Southern California
🇺🇸Los Angeles, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.